Skip to main content
. 2011 Jan 11;104(3):464–468. doi: 10.1038/sj.bjc.6606072

Table 3. Selection of BRAF mutant alleles in the progression of melanoma.

              Subcloning (no. of colonies)
Sample no. Age (years) Sex Type of melanoma Site Tissue Direct sequencinga BRAF mutationsa Wild type
PM-10 32 F NCSD Forearm FFPE Wild type 2(V600E) 38
RPM-10       Forearm FFPE V600E 7(V600E) 33
PM-16 53 F NCSD Neck Frozen V600−K601E 9(V600−K601E)+2(V600E) 30
MM-16       Cervical LN Frozen V600−K601E 27(V600-K601E) 13
PM-17 67 M NCSD Right shoulder Frozen Wild type 8(V600K)+1(K601E) 71
MM-17-1       Skin Frozen V600K 13(V600K) +1(K601E) +1(K601K) 15
MM-17-2       Right lung Frozen Wild type NE NE
MM-17-3       Small intestine Frozen V600K 14(V600K) 26
MM-17-4       Right chest wall Frozen V600K 15(V600K)+1(K601E) 54
MM-17-5       Pulmonary LN Frozen Wild type NE NE
MM-17-6       Supraclavicular LN Frozen V600K 9(V600K)+1(K601E) 30
MM-17-7       Infraclavicular LN Frozen V600K 22(V600K) 17
MM-17-8       Axillary LN Frozen V600K 12(V600K) 28
MM-17-9       Diaphragm Frozen V600K 11(V600K) 28

FFPE=formalin-fixed, paraffin-embedded tissue; LN=lymph node; MM=metastasis; NCSD=melanoma on non-chronic sun-damaged skin; NE=not examined; PM=primary melanoma; RPM=recurrent primary melanoma.

a

V600E, T1799A; V600-K601E, TGA1799-1801del; V600K, GT1798-99AA; K601E, A1801G.